Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Beta: N/A (As of Jul. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ADX:JULPHAR Gulf Pharmaceutical Industries PSC ADX:JULPHAR
54 GF Score
Price د.إ1.04
GF Value د.إ1.09
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Gulf Pharmaceutical Industries PSC Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-24), Gulf Pharmaceutical Industries PSC's Beta is Not available.

Gulf Pharmaceutical Industries PSC  (ADX:JULPHAR) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Gulf Pharmaceutical Industries PSC Beta Related Terms

Gulf Pharmaceutical Industries PSC Beta Historical Data

* Premium members only.

The historical data trend for Gulf Pharmaceutical Industries PSC's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gulf Pharmaceutical Industries PSC Beta Chart

Gulf Pharmaceutical Industries PSC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Gulf Pharmaceutical Industries PSC Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ADX:JULPHAR
54GF Score
Gulf Pharmaceutical Industries PSC ADX:JULPHAR
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gulf Pharmaceutical Industries PSC Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Is Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Overvalued in 2026?

Based on GuruFocus' analysis, Gulf Pharmaceutical Industries PSC stock appears to be undervalued. The current stock price of د.إ1.04 is trading 4.6% below its estimated GF Value™ of د.إ1.09. GuruFocus considers Gulf Pharmaceutical Industries PSC to be Fairly Valued.

Key valuation signals for ADX:JULPHAR:

  • Beta: N/A
  • GF Value™: د.إ1.09 vs. price of د.إ1.04 (4.6% below fair value)
  • GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the ADX:JULPHAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gulf Pharmaceutical Industries PSC Business Description

Address Airport Road, P.O. Box 997, Digdaga, Ras Al Khaimah, ARE
Gulf Pharmaceutical Industries PSC is in the business of manufacturing and selling medicines, drugs, and various other types of pharmaceutical and medical compounds in addition to cosmetic compounds. The company operates in four segments: Manufacturing, Trading, Investments, and others. The majority of its revenue is generated from the Manufacturing segment. The geographical segments are UAE, Other GCC countries, and Other countries. It derives maximum revenue from UAE. Its business is centered around General Medicines in the retail pharmacy channel and hospitals as well as speciality Products. Its medicines also targets therapeutic segments such as Diabetes, Gastrointestinal Tract (GIT), Respiratory, Wounds and Scars, Anti-infectives, Anemia, Gynecology, Erectile Dysfunction and Others.
54GF Score

Get the complete analysis for ADX:JULPHAR

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

د.إ1.04
Price
د.إ1.09
GF Value